Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Glycine microparticles loaded with functionalized nanoparticles for pulmonary delivery.

Chakraborty A, Royce SG, Plebanski M, Selomulya C.

Int J Pharm. 2019 Aug 30;570:118654. doi: 10.1016/j.ijpharm.2019.118654. [Epub ahead of print]

PMID:
31476378
2.

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J.

Gut. 2019 Aug 13. pii: gutjnl-2019-318512. doi: 10.1136/gutjnl-2019-318512. [Epub ahead of print]

PMID:
31409604
3.

Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease.

Royce SG, Patel KP, Mao W, Zhu D, Lim R, Samuel CS.

Br J Pharmacol. 2019 Jul;176(13):2195-2208. doi: 10.1111/bph.14666. Epub 2019 May 7.

PMID:
30883698
4.

Relaxin and fibrosis: Emerging targets, challenges, and future directions.

Kanai AJ, Konieczko EM, Bennett RG, Samuel CS, Royce SG.

Mol Cell Endocrinol. 2019 May 1;487:66-74. doi: 10.1016/j.mce.2019.02.005. Epub 2019 Feb 14. Review.

PMID:
30772373
5.

iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid.

Royce SG, Mao W, Lim R, Kelly K, Samuel CS.

FASEB J. 2019 May;33(5):6402-6411. doi: 10.1096/fj.201802307R. Epub 2019 Feb 15.

PMID:
30768365
6.

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status.

Garg M, Royce SG, Tikellis C, Shallue C, Sluka P, Wardan H, Hosking P, Monagle S, Thomas M, Lubel JS, Gibson PR.

Therap Adv Gastroenterol. 2019 Jan 18;12:1756284818822566. doi: 10.1177/1756284818822566. eCollection 2019.

7.

Insights into endotoxin-mediated lung inflammation and future treatment strategies.

Chakraborty A, Boer JC, Selomulya C, Plebanski M, Royce SG.

Expert Rev Respir Med. 2018 Nov;12(11):941-955. doi: 10.1080/17476348.2018.1523009. Epub 2018 Oct 3. Review.

PMID:
30221563
8.

Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases.

Lam M, Royce SG, Samuel CS, Bourke JE.

Pharmacol Ther. 2018 Jul;187:61-70. doi: 10.1016/j.pharmthera.2018.02.004. Epub 2018 Feb 12. Review.

PMID:
29447958
9.

Synchrotron-Fourier transform infrared maps of ovalbumin-induced murine chronic allergic airways disease: Correlation with conventional histology.

Mazarakis N, Vongsvivut J, Bambery KR, Snibson KJ, Royce SG, Karagiannis TC.

Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:103-113.

PMID:
29324919
10.

Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease.

Royce SG, Rele S, Broughton BRS, Kelly K, Samuel CS.

FASEB J. 2017 Sep;31(9):4168-4178. doi: 10.1096/fj.201700178R. Epub 2017 Jun 16.

PMID:
28626025
11.

Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases.

Royce SG, Bathgate RA, Samuel CS.

Am J Respir Crit Care Med. 2016 Dec 1;194(11):1434-1435. No abstract available.

PMID:
27905854
12.

Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation.

Lam M, Royce SG, Donovan C, Jelinic M, Parry LJ, Samuel CS, Bourke JE.

Front Pharmacol. 2016 Oct 27;7:406. eCollection 2016.

13.

Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.

Royce SG, Tominaga AM, Shen M, Patel KP, Huuskes BM, Lim R, Ricardo SD, Samuel CS.

Clin Sci (Lond). 2016 Dec 1;130(23):2151-2165. Epub 2016 Sep 19.

PMID:
27647937
14.

Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.

Royce SG, Nold MF, Bui C, Donovan C, Lam M, Lamanna E, Rudloff I, Bourke JE, Nold-Petry CA.

Am J Respir Cell Mol Biol. 2016 Dec;55(6):858-868.

PMID:
27482635
15.

Anti-fibrotic actions of relaxin.

Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG.

Br J Pharmacol. 2017 May;174(10):962-976. doi: 10.1111/bph.13529. Epub 2016 Jul 7. Review. Erratum in: Br J Pharmacol. 2017 Dec;174(24):4836.

16.

Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities.

Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR.

Aliment Pharmacol Ther. 2016 Aug;44(3):223-33. doi: 10.1111/apt.13676. Epub 2016 Jun 1.

17.

A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.

Hossain MA, Kocan M, Yao ST, Royce SG, Nair VB, Siwek C, Patil NA, Harrison IP, Rosengren KJ, Selemidis S, Summers RJ, Wade JD, Bathgate RAD, Samuel CS.

Chem Sci. 2016 Jun 1;7(6):3805-3819. doi: 10.1039/c5sc04754d. Epub 2016 Feb 26.

18.

Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.

Patel KP, Giraud AS, Samuel CS, Royce SG.

Br J Pharmacol. 2016 Jun;173(12):2016-29. doi: 10.1111/bph.13494. Epub 2016 May 5.

19.

Neonatal pneumococcal colonisation caused by Influenza A infection alters lung function in adult mice.

FitzPatrick M, Royce SG, Langenbach S, McQualter J, Reading PC, Wijburg O, Anderson GP, Stewart A, Bourke J, Bozinovski S.

Sci Rep. 2016 Mar 4;6:22751. doi: 10.1038/srep22751.

20.

A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.

Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR.

Aliment Pharmacol Ther. 2016 May;43(9):985-93. doi: 10.1111/apt.13576. Epub 2016 Mar 4.

21.

Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis.

Philpott H, Nandurkar S, Royce SG, Gibson PR.

J Gastroenterol Hepatol. 2016 Mar;31(3):590-4. doi: 10.1111/jgh.13173.

PMID:
26426817
22.

Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.

Royce SG, Shen M, Patel KP, Huuskes BM, Ricardo SD, Samuel CS.

Stem Cell Res. 2015 Nov;15(3):495-505. doi: 10.1016/j.scr.2015.09.007. Epub 2015 Sep 25.

23.

Rosiglitazone elicits in vitro relaxation in airways and precision cut lung slices from a mouse model of chronic allergic airways disease.

Donovan C, Bailey SR, Tran J, Haitsma G, Ibrahim ZA, Foster SR, Tang ML, Royce SG, Bourke JE.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 15;309(10):L1219-28. doi: 10.1152/ajplung.00156.2015. Epub 2015 Sep 18.

24.

Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction - what about recurrent episodes?

Philpott H, Nandurkar S, Royce SG, Gibson PR.

Aliment Pharmacol Ther. 2015 Oct;42(7):936. doi: 10.1111/apt.13313. No abstract available.

25.

Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.

Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, Finnie JW, Samuel CS, Royce SG, Twomey DJ, Thanigaimani S, Kalman JM, Sanders P.

J Am Coll Cardiol. 2015 Jul 7;66(1):1-11. doi: 10.1016/j.jacc.2015.04.058.

26.

The Coagulant Factor Xa Induces Protease-Activated Receptor-1 and Annexin A2-Dependent Airway Smooth Muscle Cytokine Production and Cell Proliferation.

Schuliga M, Royce SG, Langenbach S, Berhan A, Harris T, Keenan CR, Stewart AG.

Am J Respir Cell Mol Biol. 2016 Feb;54(2):200-9. doi: 10.1165/rcmb.2014-0419OC.

PMID:
26120939
27.

Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis.

Philpott HL, Nandurkar S, Thien F, Bloom S, Lin E, Goldberg R, Boyapati R, Finch A, Royce SG, Gibson PR.

Intern Med J. 2015 Sep;45(9):939-43. doi: 10.1111/imj.12790.

PMID:
25871330
28.

Lipopolysaccharide does not alter small airway reactivity in mouse lung slices.

Donovan C, Royce SG, Vlahos R, Bourke JE.

PLoS One. 2015 Mar 30;10(3):e0122069. doi: 10.1371/journal.pone.0122069. eCollection 2015.

29.

Modeling Population Exposures to Silver Nanoparticles Present in Consumer Products.

Royce SG, Mukherjee D, Cai T, Xu SS, Alexander JA, Mi Z, Calderon L, Mainelis G, Lee K, Lioy PJ, Tetley TD, Chung KF, Zhang J, Georgopoulos PG.

J Nanopart Res. 2014 Nov;16(11). pii: 2724.

30.

Alteration of Airway Reactivity and Reduction of Ryanodine Receptor Expression by Cigarette Smoke in Mice.

Donovan C, Seow HJ, Royce SG, Bourke JE, Vlahos R.

Am J Respir Cell Mol Biol. 2015 Oct;53(4):471-8. doi: 10.1165/rcmb.2014-0400OC.

PMID:
25692207
31.

Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver.

Mukherjee D, Leo BF, Royce SG, Porter AE, Ryan MP, Schwander S, Chung KF, Tetley TD, Zhang J, Georgopoulos PG.

J Nanopart Res. 2014 Oct 1;16(10):2616.

32.

Modeling in vitro cellular responses to silver nanoparticles.

Mukherjee D, Royce SG, Sarkar S, Thorley A, Schwander S, Ryan MP, Porter AE, Chung KF, Tetley TD, Zhang J, Georgopoulos PG.

J Toxicol. 2014;2014:852890. doi: 10.1155/2014/852890. Epub 2014 Oct 9.

33.

Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study.

Mukherjee D, Royce SG, Alexander JA, Buckley B, Isukapalli SS, Bandera EV, Zarbl H, Georgopoulos PG.

PLoS One. 2014 Dec 4;9(12):e113632. doi: 10.1371/journal.pone.0113632. eCollection 2014.

34.

Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC.

Antioxid Redox Signal. 2015 Jun 1;22(16):1382-424. doi: 10.1089/ars.2014.6097. Epub 2014 Dec 19. Review.

35.

Manganese concentrations in soil and settled dust in an area with historic ferroalloy production.

Pavilonis BT, Lioy PJ, Guazzetti S, Bostick BC, Donna F, Peli M, Zimmerman NJ, Bertrand P, Lucas E, Smith DR, Georgopoulos PG, Mi Z, Royce SG, Lucchini RG.

J Expo Sci Environ Epidemiol. 2015 Jul-Aug;25(4):443-50. doi: 10.1038/jes.2014.70. Epub 2014 Oct 22.

36.

Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma.

Royce SG, Patel KP, Samuel CS.

Lab Invest. 2014 Dec;94(12):1326-39. doi: 10.1038/labinvest.2014.119. Epub 2014 Sep 29.

37.

The effect of gas exchange on multiple-breath nitrogen washout measures of ventilation inhomogeneity in the mouse.

Dharmakumara M, Prisk GK, Royce SG, Tawhai M, Thompson BR.

J Appl Physiol (1985). 2014 Nov 1;117(9):1049-54. doi: 10.1152/japplphysiol.00543.2014. Epub 2014 Sep 11.

38.

Eosinophilic esophagitis: a clinicopathological review.

Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG.

Pharmacol Ther. 2015 Feb;146:12-22. doi: 10.1016/j.pharmthera.2014.09.001. Epub 2014 Sep 6. Review.

PMID:
25200122
39.

Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.

Royce SG, Lim CX, Patel KP, Wang B, Samuel CS, Tang ML.

Clin Exp Allergy. 2014 Nov;44(11):1399-408. doi: 10.1111/cea.12391.

PMID:
25113628
40.

Risk factors for eosinophilic esophagitis.

Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR.

Clin Exp Allergy. 2014 Aug;44(8):1012-9. doi: 10.1111/cea.12363. Review.

PMID:
24990069
41.

Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease.

Samuel CS, Bodaragama H, Chew JY, Widdop RE, Royce SG, Hewitson TD.

Hypertension. 2014 Aug;64(2):315-22. doi: 10.1161/HYPERTENSIONAHA.114.03594.

PMID:
24866131
42.

Role of caveolin-1 in asthma and chronic inflammatory respiratory diseases.

Royce SG, Le Saux CJ.

Expert Rev Respir Med. 2014 Jun;8(3):339-47. doi: 10.1586/17476348.2014.905915. Epub 2014 Apr 18. Review.

PMID:
24742020
43.

Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis.

Royce SG, Moodley Y, Samuel CS.

Pharmacol Ther. 2014 Mar;141(3):250-60. doi: 10.1016/j.pharmthera.2013.10.008. Epub 2013 Oct 25. Review.

PMID:
24513131
44.

Cell cycle effects of L-sulforaphane, a major antioxidant from cruciferous vegetables: The role of the anaphase promoting complex.

Shelley Z, Royce SG, Ververis K, Karagiannis TC.

Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:11-6.

PMID:
24392461
45.

Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.

Royce SG, Karagiannis TC.

Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):44-8. doi: 10.1097/ACI.0000000000000029. Review.

PMID:
24322009
46.

Airway hyperresponsiveness is associated with airway remodeling but not inflammation in aging Cav1-/- mice.

Gabehart KE, Royce SG, Maselli DJ, Miyasato SK, Davis EC, Tang ML, Jourdan Le Saux C.

Respir Res. 2013 Oct 21;14:110. doi: 10.1186/1465-9921-14-110.

47.

Differential effects of allergen challenge on large and small airway reactivity in mice.

Donovan C, Royce SG, Esposito J, Tran J, Ibrahim ZA, Tang ML, Bailey S, Bourke JE.

PLoS One. 2013 Sep 6;8(9):e74101. doi: 10.1371/journal.pone.0074101. eCollection 2013.

48.

Mechanistic insights into the contribution of epithelial damage to airway remodeling. Novel therapeutic targets for asthma.

Royce SG, Li X, Tortorella S, Goodings L, Chow BS, Giraud AS, Tang ML, Samuel CS.

Am J Respir Cell Mol Biol. 2014 Jan;50(1):180-92. doi: 10.1165/rcmb.2013-0008OC.

PMID:
23980699
49.

Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation.

Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P.

Heart Rhythm. 2013 Jan;10(1):90-100. doi: 10.1016/j.hrthm.2012.08.043. Epub 2012 Sep 1.

PMID:
23063864
50.

Histone deacetylase inhibitors: can we consider potent anti-neoplastic agents for the treatment of asthma?

Royce SG, Ververis K, Karagiannis TC.

Ann Clin Lab Sci. 2012 Summer;42(3):338-45. Review.

PMID:
22964624

Supplemental Content

Loading ...
Support Center